Merck (MRK)Mediolanum International Funds Ltd reduced its stake -18K shares

496K

Shares reported · -18K vs prior quarter

0.55%

Disclosed portfolio weight

$64.1M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed sale of MRK — reported range $15,001 - $50,000
2. May 21, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
3. Jun 12, 2026FDAFDA drug approval: Welireg
4. Jun 12, 2026FDAFDA drug approval: Keytruda
5. Jun 12, 2026FDAFDA drug approval: Keytruda Qlex
6. Jun 12, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
7. Jun 12, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
8. Jun 23, 2026Federal contract · $23K obligatedDepartment of Veterans Affairs awarded Merck: $23K obligated to date
9. Jun 24, 2026FDAFDA drug approval: Keytruda
10. Jun 24, 2026FDAFDA drug approval: Keytruda Qlex
11. Jul 10, 2026FDAFDA drug approval: Keytruda
12. Jul 10, 2026FDAFDA drug approval: Keytruda Qlex

What came next

1. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 5, 2026Insider · 2 peopleInsiders: 6 sales (~$9.2M)
3. Aug 6, 2026Insider · 2 peopleInsiders: 4 sales (~$2.8M)
4. Aug 10, 2026InsiderOfficer sold ~$2.71M of MRK shares in the open market
5. Aug 11, 2026Insider · 1 personInsiders: 2 sales (~$1.7M)
6. Aug 12, 2026Insider · 2 peopleInsiders: 3 sales (~$12.3M)
7. Aug 13, 2026InsiderOfficer sold ~$1.35M of MRK shares in the open market
8. Aug 19, 2026Congress · 1 personMembers of Congress: 2 purchases
9. Sep 14, 2026Federal contract · $1.6M obligatedDepartment of Health and Human Services awarded Merck: $1.63M obligated to date
10. Sep 21, 2026FDAFDA drug approval: Winrevair
11. Sep 24, 2026FDAFDA drug approval: Welireg
12. Sep 24, 2026CongressDisclosed partial sale of MRK — reported range $1,001 - $15,000

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Merck

For Merck, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 123 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.

How this filing works

• SEC Form 13F

Other disclosures at Merck

• House Clerk periodic transaction reportOct 7, 2026
• USAspending.gov award recordSep 17, 2026
• House Clerk periodic transaction reportSep 9, 2026
• House Clerk periodic transaction reportSep 9, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026

Everything OQRO holds on this company is on its MRK page.